XML 41 R9.htm IDEA: XBRL DOCUMENT v2.4.0.8
LIQUIDITY
12 Months Ended
Dec. 31, 2013
LIQUIDITY  
LIQUIDITY

3. LIQUIDITY

        As of December 31, 2013, the Company had approximately $1.1 million in cash and our cash balance at March 1, 2014 was approximately $11.2 million. The Company is not currently conducting uranium production activities and has no uranium inventory. The Company is not projecting significant sales revenue and related cash inflows for 2014.

        On November 13, 2013, the Company and its largest stockholder, RCF entered into a Loan Agreement (the "Loan Agreement") whereby RCF agreed, subject to the terms and conditions set forth in the Loan Agreement, to provide a secured convertible loan facility of up to $15.0 million to the Company. The facility consists of three tranches of $5.0 million each. RCF advanced $3.0 million of the first $5.0 million tranche shortly following the closing of the Loan Agreement, and on January 29, 2014, the Company's stockholders, excluding RCF, approved the Loan Agreement and the issuance of shares thereunder. Following such approval, RCF advanced the remaining $2.0 million of the first tranche. Two additional tranches of $5.0 million each are available under the Loan Agreement, subject to a determination by the Company's Board of Directors to draw such amounts and the terms and conditions of the RCF Loan Agreement.

        On October 28, 2011, the Company entered into an At-The-Market Sales Agreement with BTIG, LLC, allowing it to sell from time to time, shares of its common stock having an aggregate offering price of up to $15.0 million, through an "at-the-market" equity offering program ("ATM Sales Agreement"). From January 17, 2014 to January 31, 2014, the Company sold 523,350 shares of common stock for net proceeds of $1.9 million under its ATM Sales Agreement. The Company has a total of $7.1 million available for future sales under the ATM Sales Agreement.

        On February 12, 2014, the Company completed its $10.3 million registered direct offering with the issuance of 3,960,000 shares of common stock at a price of $2.60 per share for net proceeds of $9,472,320. The Company and RCF are currently discussing the level of participation accorded RCF per its anti-dilution rights under the Loan Agreement.

        The Company expects that its existing cash, ATM Sales Agreement and other public offerings will provide it the necessary liquidity for 2014. Additional funding under the ATM Sales Agreement or other public offerings is subject to market conditions. In the event funds are not available, we may be required to change our planned business strategies.